Swiss Stocks Fair Value: Roche, Novartis, Nestle…
Of the 56 Swiss companies below that have an ATLAS fair value estimate, 20 trade more than 8% below the model's central estimate, 10 within 8% of it and 26 more than 8% above it (median: price in line with fair value). Roche is the largest (market cap $361B); 54 of the 60 pay a dividend, with a median yield of 2.6%.
Updated Nov 3, 2026 · Source: EODHD / ATLAS model
| # | Company | Price | ATLAS fair value | Price vs fair value |
|---|---|---|---|---|
| 1 | RocheROP.SW | CHF 397.20 | CHF 470.74 | -16% |
| 2 | NovartisNOVN.SW | CHF 131.52 | CHF 212.84 | -38% |
| 3 | NestleNESN.SW | CHF 84.64 | CHF 86.55 | -2.2% |
| 4 | ABBABBN.SW | CHF 71.34 | CHF 52.53 | +36% |
| 5 | UBSUBSG.SW | CHF 39.79 | CHF 27.63 | +44% |
| 6 | Compagnie Financière RichemontCFR.SW | CHF 166.95 | CHF 121.30 | +38% |
| 7 | Zurich InsuranceZURN.SW | CHF 623.60 | CHF 1,023 | -39% |
| 8 | Swiss ReSREN.SW | CHF 153.65 | CHF 118.95 | +29% |
| 9 | LonzaLONN.SW | CHF 648.20 | CHF 409.81 | +58% |
| 10 | Galderma Group NGALD.SW | CHF 191.50 | ||
| 11 | GivaudanGIVN.SW | CHF 4,000 | CHF 3,324 | +20% |
| 12 | HolcimHOLN.SW | CHF 71.10 | CHF 73.51 | -3.3% |
| 13 | SwisscomSCMN.SW | CHF 700.00 | CHF 410.46 | +71% |
| 14 | SandozSDZ.SW | CHF 82.86 | CHF 59.02 | +40% |
| 15 | SikaSIKA.SW | CHF 184.75 | CHF 203.16 | -9.1% |
| 16 | Schindler PsSCHP.SW | CHF 306.40 | CHF 373.09 | -18% |
| 17 | SchindlerSCHN.SW | CHF 297.50 | CHF 369.51 | -19% |
| 18 | Kuehne & NagelKNIN.SW | CHF 241.40 | CHF 191.22 | +26% |
| 19 | AlconALC.SW | CHF 60.42 | CHF 65.13 | -7.2% |
| 20 | Swiss LifeSLHN.SW | CHF 959.60 | CHF 733.12 | +31% |
| 21 | HelvetiaHBAN.SW | CHF 219.60 | CHF 78.83 | +179% |
| 22 | EMS-CHEMIEEMSN.SW | CHF 856.50 | CHF 544.66 | +57% |
| 23 | SGSSGSN.SW | CHF 103.60 | CHF 105.13 | -1.5% |
| 24 | Chocoladefabriken Lindt & Spruengli AG PartLISP.SW | CHF 8,505 | CHF 7,977 | +6.6% |
| 25 | VATVACN.SW | CHF 564.60 | ||
| 26 | GeberitGEBN.SW | CHF 589.00 | CHF 396.97 | +48% |
| 27 | AmerizeAMRZ.SW | CHF 35.36 | CHF 60.07 | -41% |
| 28 | Sonova HSOON.SW | CHF 285.20 | CHF 232.42 | +23% |
| 29 | PartnersPGHN.SW | CHF 654.00 | CHF 652.65 | +0.2% |
| 30 | StraumannSTMN.SW | CHF 100.65 | CHF 56.60 | +78% |
| 31 | Julius Baer GruppeBAER.SW | CHF 69.56 | CHF 73.24 | -5.0% |
| 32 | Logitech InternationalLOGN.SW | CHF 78.52 | CHF 94.30 | -17% |
| 33 | Banque Cantonale VaudoiseBCVN.SW | CHF 132.70 | CHF 86.97 | +53% |
| 34 | Swiss Prime SiteSPSN.SW | CHF 131.70 | CHF 54.75 | +141% |
| 35 | BelimoBEAN.SW | CHF 793.50 | ||
| 36 | The SwatchUHR.SW | CHF 182.70 | CHF 154.39 | +18% |
| 37 | Swatch Group AG Class NUHRN.SW | CHF 35.10 | CHF 30.32 | +16% |
| 38 | PSP Swiss PropertyPSPN.SW | CHF 154.50 | CHF 142.36 | +8.5% |
| 39 | Accelleron IndustriesACLN.SW | CHF 65.45 | CHF 73.25 | -11% |
| 40 | BKWBKW.SW | CHF 124.00 | CHF 138.75 | -11% |
| 41 | VZVZN.SW | CHF 169.80 | CHF 89.68 | +89% |
| 42 | BachemBANB.SW | CHF 83.70 | CHF 38.82 | +116% |
| 43 | AvoltaAVOL.SW | CHF 47.96 | CHF 52.62 | -8.9% |
| 44 | Luzerner KantonalbankLUKN.SW | CHF 129.00 | CHF 112.39 | +15% |
| 45 | Barry CallebautBARN.SW | CHF 1,209 | CHF 1,336 | -9.5% |
| 46 | Flughafen ZurichFHZN.SW | CHF 208.80 | CHF 340.77 | -39% |
| 47 | SulzerSUN.SW | CHF 185.50 | CHF 210.92 | -12% |
| 48 | SFSSFSN.SW | CHF 141.20 | CHF 234.92 | -40% |
| 49 | SIG CombiblocSIGN.SW | CHF 14.70 | CHF 28.67 | -49% |
| 50 | SwissquoteSQN.SW | CHF 34.44 | CHF 29.65 | +16% |
| 51 | VontobelVONN.SW | CHF 91.90 | CHF 90.45 | +1.6% |
| 52 | YpsomedYPSN.SW | CHF 403.00 | CHF 424.64 | -5.1% |
| 53 | EmmiEMMN.SW | CHF 946.00 | CHF 1,085 | -13% |
| 54 | TemenosTEMN.SW | CHF 76.00 | CHF 121.32 | -37% |
| 55 | EFG InternationalEFGN.SW | CHF 16.16 | CHF 10.00 | +62% |
| 56 | Georg FischerGF.SW | CHF 57.10 | ||
| 57 | DKSHDKSH.SW | CHF 77.00 | CHF 113.83 | -32% |
| 58 | InficonIFCN.SW | CHF 171.40 | CHF 75.66 | +127% |
| 59 | Galenica SanteGALE.SW | CHF 88.65 | CHF 109.80 | -19% |
| 60 | St Galler KantonalbankSGKN.SW | CHF 704.00 | CHF 712.36 | -1.2% |
Price vs fair value = latest close ÷ ATLAS fair value − 1: negative means the price is below the model's central estimate, positive above. Ordered by market capitalization. Prices and fair values are in each company's trading currency.
How this list is built
Ranking: companies are ordered by market capitalization in US dollars (EODHD). Investment funds and trusts and duplicate share classes are removed. ATLAS publishes 154 companies (Switzerland); the 60 largest are shown.
Fair value: ATLAS estimates a fair value per share every night with its valuation model (discounted cash flow and/or sector multiples, depending on the company), with a low–high range and a low, medium or high confidence label. Latest model run: Nov 2, 2026.
Price vs fair value is a description of the model, not a forecast and not a recommendation to buy or sell. Models can be wrong; a price below the estimate can stay there. Dividend yield is the forward yield reported by EODHD.
Frequently asked questions
Are Swiss stocks undervalued?
ATLAS does not give a verdict: it compares each price with its own fair value estimate. As of Nov 3, 2026, of the 56 Swiss companies with an estimate, 20 trade more than 8% below the model's central estimate, 10 within 8% and 26 more than 8% above (median: price in line with fair value). This describes a model, not a forecast.
How does ATLAS estimate the fair value of European stocks?
Every night the ATLAS valuation model estimates a fair value per share (discounted cash flow and/or sector multiples, depending on the company) with a low–high range and a confidence label. Price vs fair value is the latest close divided by the central estimate, minus 1. The latest run in this list is from Nov 2, 2026.
Which Swiss companies trade furthest from their ATLAS fair value?
As of Nov 3, 2026, among the companies listed, SIG Combibloc has the largest gap below the model's central estimate (price -49% vs fair value) and Helvetia the largest gap above (price +179%). These are model outputs, not recommendations.
Is this a recommendation to buy or sell?
No. This page is information only, not investment advice. ATLAS estimates come from statistical models using public data; they can be wrong, and past results do not guarantee future ones.
More on European stocks
- European dividend calendar
- Best dividend stocks in Switzerland
- Stocks below fair value in Switzerland
- All Switzerland stocks
- How ATLAS estimates fair value
- All stocks
Other countries
Information only, not investment advice. Disclaimer